Date
Title
View
06 Jul 18
SYGNIS AG: SYGNIS AG announces outcome of Annual General Meeting 2018 (news with additional features)
View
30 May 18
SYGNIS AG: SYGNIS AG proposes at AGM change of name to Expedeon AG (news with additional features)
View
11 May 18
SYGNIS AG: SYGNIS AG reports strong financial results for first quarter of 2018 (news with additional features)
View
09 May 18
SYGNIS AG: SYGNIS introduces 2view unique Western blot detection technology (news with additional features)
View
08 May 18
SYGNIS AG: SYGNIS completes acquisition of TGR Biosciences (news with additional features)
View
25 Apr 18
SYGNIS AG: SYGNIS AG reports financial results for fiscal year 2017 – financial guidance achieved (news with additional features)
View
19 Mar 18
SYGNIS AG: SYGNIS AG to raise capital to acquire TGR Biosciences (news with additional features)
View
15 Mar 18
SYGNIS AG: SYGNIS announces completion of Sales and Marketing team restructuring to support continued strong revenue growth (news with additional features)
View
06 Mar 18
SYGNIS completes integration of acquired companies’ products and services under Expedeon brand name (news with additional features)
View
21 Feb 18
SYGNIS AG: SYGNIS AG extends OEM agreement with leading global research tools provider (news with additional features)
View
06 Dec 17
SYGNIS AG: SYGNIS AG launches TruePrime(TM) apoptotic cell free DNA amplification kit for the liquid biopsy market (news with additional features)
View
28 Nov 17
SYGNIS AG: SYGNIS AG signs supply agreement with US Biological for the Lightning-Link(R) antibody labelling technology (news with additional features)
View